![Colby Shad Thaxton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colby Shad Thaxton
Fondateur chez Aurasense LLC
Postes actifs de Colby Shad Thaxton
Sociétés | Poste | Début | Fin |
---|---|---|---|
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - | - |
International Institute For Nanotechnology | Corporate Officer/Principal | - | - |
Institute for BioNanotechnology in Medicine
![]() Institute for BioNanotechnology in Medicine Miscellaneous Commercial ServicesCommercial Services Institute for BioNanotechnology in Medicine promotes translational bionanotechology research that has the potential to revolutionize regenerative medicine and produce targeted therapeutics. It performs research in fields that can have profound impacts on regenerative medicine and targeted therapeutics, such as self-assembly, tissue engineering, genomics, smart drug delivery, and developing new bionanotechnologies. The company is headquartered in Chicago, IL. | Corporate Officer/Principal | - | - |
Aurasense LLC | Fondateur | 01/12/2009 | - |
Corporate Officer/Principal | 01/12/2009 | - | |
Zylem Biosciences, Inc. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - |
Historique de carrière de Colby Shad Thaxton
Anciens postes connus de Colby Shad Thaxton
Sociétés | Poste | Début | Fin |
---|---|---|---|
EXICURE, INC. | Directeur/Membre du Conseil | 01/01/2011 | 11/09/2019 |
Fondateur | 01/01/2011 | 11/09/2019 | |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Directeur/Membre du Conseil | 01/01/2011 | - |
Fondateur | 01/01/2011 | - |
Formation de Colby Shad Thaxton
Northwestern University | Doctorate Degree |
University of Colorado Boulder | Undergraduate Degree |
Feinberg School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Founder | 4 |
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Sectorielle
Consumer Services | 5 |
Health Technology | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXICURE, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Aurasense LLC | |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Institute for BioNanotechnology in Medicine
![]() Institute for BioNanotechnology in Medicine Miscellaneous Commercial ServicesCommercial Services Institute for BioNanotechnology in Medicine promotes translational bionanotechology research that has the potential to revolutionize regenerative medicine and produce targeted therapeutics. It performs research in fields that can have profound impacts on regenerative medicine and targeted therapeutics, such as self-assembly, tissue engineering, genomics, smart drug delivery, and developing new bionanotechnologies. The company is headquartered in Chicago, IL. | Commercial Services |
Zylem Biosciences, Inc. | Health Technology |
- Bourse
- Insiders
- Colby Shad Thaxton
- Expérience